Acquisition Announced
Abbott acquisition of Exact Sciences
US$23bn enterprise value
Announced 20 Nov 2025 · US$105.00 cash per share
Advisers
Exact Sciences
Target
- Financial adviser
- Legal adviser
- Fairness opinion
- Target
- Exact Sciences
- Acquirer
- Abbott
- Target based in
- United States
- Buyer based in
- United States
- Equity value
- US$21bn
- Sector
- Diagnostics
In the league tables
Similar deals
- Waters acquisition of BD Biosciences & Diagnostic Solutions business Jul 2025 · US$19bn · Life Sciences
- Merck KGaA acquisition of Bio-Techne Jun 2026 · US$11bn · Life Sciences
- Danaher acquisition of Masimo Feb 2026 · US$9.9bn · Medtech
- Curium US Holdings acquisition of Lantheus Holdings Aug 2026 · US$8bn · Radiopharmaceuticals
- Tempus AI acquisition of Personalis Jul 2026 · US$1.9bn · Diagnostics
Sources
- 20 Nov 2025 Abbott — Abbott acquisition of Exact Sciences sec.gov
- 9 Jan 2026 Definitive merger proxy statement (DEFM14A), EXACT SCIENCES CORP sec.gov
- 28 Jul 2026 Abbott — Abbott acquisition of Exact Sciences sec.gov


